J&J Device Sales May Reflect Slowdown In Procedure Volumes, Firm Says
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's sluggish growth in first-quarter medical device and diagnostics sales may be due in part to an overall slowdown in surgical procedure volumes in the United States, the company says